|
|
|
Insider
Information: |
Brennan Daniel J. |
Relationship: |
Director |
City: |
Natick |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
272,248 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$19,975,137 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
272,248 |
|
|
Total
Value |
$19,975,137 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
Percentage
Gain/Loss : |
0.0%
|
8.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Boston Scientific Corp |
BSX |
EVP and CFO |
2024-02-20 |
271,542 |
|
0 |
Premium* |
|
Nuance Communications Inc |
NUAN |
Director |
2022-03-04 |
0 |
2018-09-10 |
0 |
Premium* |
|
Waters Corp |
WAT |
Director |
2024-01-02 |
706 |
2022-11-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
169 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2021-02-22 |
4 |
D |
$39.20 |
$100,744 |
D/D |
(2,570) |
282,352 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2021-02-23 |
4 |
AS |
$39.23 |
$974,704 |
D/D |
(24,846) |
282,352 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2019-10-02 |
4 |
AS |
$39.44 |
$807,040 |
D/D |
(20,462) |
214,960 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2019-02-14 |
4 |
AS |
$39.57 |
$887,912 |
D/D |
(22,438) |
279,183 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2019-02-15 |
4 |
D |
$40.01 |
$73,858 |
D/D |
(1,846) |
281,489 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2019-03-14 |
4 |
AS |
$40.02 |
$1,855,545 |
D/D |
(46,360) |
214,960 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2019-02-20 |
4 |
D |
$40.11 |
$1,032,953 |
D/D |
(25,753) |
313,672 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2019-02-28 |
4 |
D |
$40.12 |
$79,919 |
D/D |
(1,992) |
325,543 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2019-02-22 |
4 |
D |
$40.52 |
$104,380 |
D/D |
(2,576) |
316,890 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2019-02-23 |
4 |
D |
$40.52 |
$96,640 |
D/D |
(2,385) |
319,870 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2019-02-24 |
4 |
D |
$40.52 |
$103,285 |
D/D |
(2,549) |
323,055 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2019-03-04 |
4 |
AS |
$40.84 |
$2,622,553 |
D/D |
(64,223) |
261,320 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2020-02-13 |
4 |
AS |
$42.03 |
$860,041 |
D/D |
(20,463) |
230,247 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2020-02-14 |
4 |
D |
$42.31 |
$710,004 |
D/D |
(16,781) |
250,430 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2020-02-15 |
4 |
D |
$42.31 |
$79,797 |
D/D |
(1,886) |
252,697 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2022-01-01 |
4 |
D |
$42.48 |
$172,341 |
D/D |
(4,057) |
272,379 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2022-02-18 |
4 |
D |
$42.55 |
$69,952 |
D/D |
(1,644) |
270,789 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2022-02-21 |
4 |
D |
$42.55 |
$69,101 |
D/D |
(1,624) |
272,826 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2020-02-21 |
4 |
D |
$42.62 |
$70,749 |
D/D |
(1,660) |
254,697 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2020-02-22 |
4 |
D |
$42.62 |
$112,005 |
D/D |
(2,628) |
257,863 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2020-02-23 |
4 |
D |
$42.62 |
$103,694 |
D/D |
(2,433) |
260,795 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2022-02-22 |
4 |
AS |
$42.75 |
$2,273,621 |
D/D |
(53,182) |
272,826 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2022-02-17 |
4 |
D |
$42.83 |
$87,073 |
D/D |
(2,033) |
268,727 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2022-02-15 |
4 |
AS |
$43.47 |
$397,142 |
D/D |
(9,136) |
266,177 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2022-02-16 |
4 |
AS |
$43.70 |
$532,580 |
D/D |
(12,187) |
266,177 |
0 |
% |
|
169 Records found
|
|
Page 6 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|